A human monoclonal autoantibody to a nucleolar structure

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• Scleroderma is an autoimmune disease characterized by the production of autoantibodies.
• Identifying specific autoantigens is crucial for understanding disease pathogenesis and developing diagnostic tools.

Purpose of the Study:

• To generate and characterize a monoclonal antibody from a scleroderma patient targeting a nucleolar antigen.
• To identify the specific autoantigens recognized by this antibody.

Main Methods:

• Isolation and transformation of peripheral blood lymphocytes from a scleroderma patient.
• Fusion with heteromyeloma cells to produce hybridomas.
• Screening for autoantibody production against nucleoprotamine using ELISA.
• Cloning positive hybridomas by limiting dilution.
• Characterization of the antibody using indirect immunofluorescence, ELISA with recombinant antigens, and immunoblotting.
• Antigen purification and SDS-PAGE analysis.
• Screening purified antigen with characterized antisera.

Main Results:

• A monoclonal antibody, CDC-1, was generated and recognized a nucleolar antigen.
• CDC-1 reacted with Ro/SS-A, U1 (RNP), and Sm antigens in ELISA.
• Immunoblotting identified a 60 kD target structure.
• Purified antigen analysis revealed bands at 60, 55, and 39 kD.
• The CDC-1 antigen showed reactivity with antisera against Ro/SS-A.

Conclusions:

• The monoclonal antibody CDC-1 recognizes a nucleolar antigen associated with Ro/SS-A.
• This finding contributes to the understanding of autoantigen targets in scleroderma and related autoimmune conditions.